Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Gynecologic Oncology|July 30, 2025
Enhancing predictive accuracy: Assessing the laparoscopic hysterectomy readmission score in a diverse endometrial cancer populationMichelle D S Lightfoot, Jennifer A Sinnott, Caitlin E Meade, et al.American Journal of Obstetrics and Gynecology|March 14, 2022
More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancerDavid A Barrington, Jennifer A Sinnott, Danaye Nixon, et al.Gynecologic Oncology|May 7, 2022
Less is more: Abdominal closure protocol does not reduce surgical site infection after hysterectomyJoseph A DeMari, Glenn P Boyles, David A Barrington, et al.Gynecologic Oncology|October 11, 2016
Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes?David A Barrington, Sarah E Dilley, Emily E Landers, et al.Gynecologic Oncology|March 1, 2018
Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment ClinicDavid A Barrington, Macie L Champion, Teresa K L Boitano, et al.Gynecologic Oncology|June 15, 2019
Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment ClinicTeresa K L Boitano, David A Barrington, Sadhvi Batra, et al.Gynecologic Oncology Reports|July 20, 2022
High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitorsCorinne A Calo, David A Barrington, Morgan Brown, et al.Gynecologic Oncology|March 30, 2024
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancerCourtney J Riedinger, David A Barrington, Christa I Nagel, et al.Gynecologic Oncology Reports|February 23, 2024
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State UniversityMonica D Levine, Vincent M Wagner, Courtney J Riedinger, et al.Surgical Oncology|September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerationsDavid A Barrington, Ashley S Felix, Rieham Owda, et al.Pageof 3